Akouos (NASDAQ:AKUS) reported quarterly losses of $(0.58) per share. This is a 12.12 percent increase over losses of $(0.66) per share from the same period last year.
Barclays Maintains Equal-Weight on Pfizer, Lowers Price Target to $44
Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $50 to $44.